Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 4/20 | 0.42 |
| ▸ | THRA | P10827 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.37 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL816412 | 1.00 | THRB (0.42) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL19757256 | 1.00 | THRB (0.42) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL815712 | 0.99 | THRB (0.41) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL15398098 | 0.98 | THRB (0.41) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL816972 | 0.98 | THRB (0.43) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL12733661 | 0.98 | THRB (0.41) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL12975846 | 0.97 | THRB (0.40) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL12141963 | 0.97 | THRB (0.41) | THRBTHRAHPGDTSHRNFKB1 | |
| SCHEMBL816326 | 0.96 | THRB (0.39) | THRBTHRAHPGDTSHRPPARG | |
| SCHEMBL21663507 | 0.96 | THRA (0.40) | THRBTHRAHPGDTSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370740-B2 | Method for producing ester group-containing compound | DIC CORPORATION (JP) | 2022-06-28 | — | — | US | disclosed |
| EP-3438134-B1 | POLYMERIZABLE COMPOSITION, CURED OBJECT, OPTICAL FILM FOR DISPLAY, AND PROCESS FOR PRODUCING CURED OBJECT | ADEKA CORP (JP) | 2021-05-05 | — | — | EP | disclosed |
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| US-10647662-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2020-05-12 | — | — | US | disclosed |
| EP-2695930-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | DAINIPPON INK & CHEMICALS (JP) | 2019-09-11 | — | — | EP | disclosed |
| EP-2261201-B1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE COMPOUND | DAINIPPON INK & CHEMICALS (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20180002276-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2018-01-04 | — | — | US | disclosed |
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170073581-A1 | MIXTURE THAT INCLUDES COMPOUND CONTAINING MESOGENIC GROUP | DIC CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-7910021-B2 | Polymerizable optical active compound and polymerizable composition containing the same | ADEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | ADEKA CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
| US-20100328601-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL DISPLAY USING THE LIQUID CRYSTAL COMPOSITION | ADEKA CORPORATION (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100328601-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL DISPLAY USING THE LIQUID CRYSTAL COMPOSITION | ADEKA CORPORATION (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2261201-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE COMPOUND | Adeka Corporation (JP) | 2010-12-15 | — | — | EP | disclosed |
| EP-2243813-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL DISPLAY ELEMENT COMPRISING THE LIQUID CRYSTAL COMPOSITION | Adeka Corporation (JP) | 2010-10-27 | — | — | EP | disclosed |
| US-7754912-B2 | acrylate compound as intermediate for a liquid crystal polymer | ADEKA CORPORATION (JP) | 2010-07-13 | — | — | US | disclosed |
| US-20100032620-A1 | POLYMERIZABLE OPTICAL ACTIVE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090247782-A1 | NOVEL POLYMERIZABLE COMPOUNDS | ADEKA CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370740-B2 | Method for producing ester group-containing compound | COASY, TAF5, TAF9 | THRB 4843/4885THRA 4791/4885HPGD 1044/4885 |
| US-20100032620-A1 | POLYMERIZABLE OPTICAL ACTIVE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE SAME | C1S, PYM1, MCCC2 | THRB 3247/4885THRA 2790/4885HPGD 4696/4885 |
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | SMC4, PHOSPHO1, SMCHD1 | THRB 4883/4885THRA 4853/4885HPGD 4408/4885 |
| US-10647662-B2 | Polymerizable compound and optically anisotropic body | RCC1, SMC4, SMCHD1 | THRB 4796/4885THRA 4729/4885HPGD 4355/4885 |
| US-20110037025-A1 | TRIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING SAME | PYM1, MT-CO1, MAT1A | THRB 341/4885THRA 426/4885HPGD 3793/4885 |
| US-20180002276-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | RCC1, SMC4, SMCHD1 | THRB 4796/4885THRA 4729/4885HPGD 4355/4885 |
| US-20090247782-A1 | NOVEL POLYMERIZABLE COMPOUNDS | CCNT1, CCNE2, MYB | THRB 3445/4885THRA 2438/4885HPGD 606/4885 |
| US-10723952-B2 | Polymerizable compound and optically anisotropic body | SMC4, SMCHD1, PHOSPHO1 | THRB 4884/4885THRA 4864/4885HPGD 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.